Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» ovarian cancer
ovarian cancer
Prima BioMed To Get Key Data In Second Half
Seeking Alpha
Wed, 01/30/13 - 01:40 pm
Prima BioMed
Cvac
epithelial ovarian cancer
ovarian cancer
Merck and Endocyte say EU is reviewing vintafolide as a treatment for ovarian cancer
Yahoo/AP
Tue, 11/27/12 - 01:08 pm
Merck
Endocyte
Europe
vintafolide
ovarian cancer
Prima BioMed announces interim data from CAN-003 trial
Yahoo/Fly on the Wall
Mon, 10/15/12 - 11:43 am
Prima BioMed
CAN-003
ovarian cancer
Myriad Wins Patent Ruling Again
Yahoo/Zacks
Tue, 08/21/12 - 11:40 am
Myriad Genetics
patents
breast cancer
ovarian cancer
Bracanalysis
Clovis Oncology ovarian cancer treatment receives orphan status
Yahoo/Fly on the Wall
Fri, 08/3/12 - 11:26 am
ovarian cancer
orphan drugs
Clovis Oncology
Biotech All Stars Buy Castoff Experimental Merck Cancer Drug
Forbes
Wed, 06/6/12 - 03:30 pm
Merck
Tesaro
niraparib
breast cancer
ovarian cancer
US FDA okays Ambit Biosciences & Teva's IND for CEP-32496, a novel BRAF inhibitor
Pharmabiz
Sat, 05/19/12 - 12:26 pm
Ambit Biosciences
Teva Pharmaceuticals
CEP-32496
cancer
melanoma
lung cancer
thyroid cancer
colon cancer
ovarian cancer
Endocyte Scores With Merck Partnership
Seeking Alpha
Sun, 04/22/12 - 12:13 pm
Endocyte
Merck
vintafolide
ovarian cancer
non-small cell lung cancer
Endocyte Gets Big Deal But More Validation Needed
Seeking Alpha
Wed, 04/18/12 - 11:39 am
Merck
Endocyte
EC145
ovarian cancer
Endocyte Doubles on Ovarian Drug Partnership With Merck
Bloomberg
Mon, 04/16/12 - 11:28 am
Merck
Endocyte
vintafolide
ovarian cancer
Early Submission = 60% Pop
Motley Fool
Sat, 03/17/12 - 10:34 am
Endocyte
EC145
ovarian cancer
Endocyte rockets 60% on EU update
Marketwatch
Thu, 03/15/12 - 09:10 am
Endocyte
Europe
ovarian cancer
EC145
EC20
Zeltia Soars After Agreement With Janssen on Yondelis for U.S.
Bloomberg
Tue, 12/27/11 - 12:31 pm
Janssen Pharmaceuticals
Zeltia
Yondelis
cancer
ovarian cancer
EU OKs Roche's Avastin for ovarian cancer
Reuters
Fri, 12/23/11 - 08:50 am
Europe
Avastin
ovarian cancer
Roche
AstraZeneca abandoning anti-ovarian cancer drug, warns antidepressant not testing well
Yahoo/AP
Tue, 12/20/11 - 10:50 am
antidepressants
Targacept
ovarian cancer
AstraZeneca
TC-5214
olaparib
Endocyte plunges on drug study results
Marketwatch
Tue, 12/13/11 - 11:56 am
Endocyte
EC145
ovarian cancer
J&J’s Doxil/Caelyx shortages affect ovarian cancer trials
FT.com
Wed, 10/19/11 - 12:04 pm
JNJ
drug shortages
Doxil
Caelyx
ovarian cancer
EntreMed shares spike on PhII cancer data
Fierce Biotech
Mon, 10/3/11 - 11:42 am
EntreMed
ENMD-2076
ovarian cancer
RXi Licenses Novel, Targeted Cancer Vaccine for Gynecological Cancers
Yahoo/Zacks.com
Thu, 09/22/11 - 11:16 am
vaccines
RXi Pharmaceuticals
ovarian cancer
gynecological cancers
No Post-IPO Blues for Endocyte
Seeking Alpha
Wed, 07/13/11 - 04:50 pm
IPOs
Endocyte
ovarian cancer
EC145
small molecule drugs
Pages
« first
‹ previous
…
8
9
10
11
12
13
14
15
16
next ›
last »